<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03485248</url>
  </required_header>
  <id_info>
    <org_study_id>68923417.0.0000.5699</org_study_id>
    <nct_id>NCT03485248</nct_id>
  </id_info>
  <brief_title>People Living With HIV/AIDS, Nitrate, Endotelial Function, Arterial Stiffness and Skeletal Muscle Oxygenation</brief_title>
  <official_title>Effect of Ingestion of Beet Juice on Endothelial Function, Arterial Stiffness and Muscle Oxygenation Parameters in People Living With HIV / AIDS Using Antiretroviral Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal do Rio de Janeiro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Federal do Rio de Janeiro</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Administration of antiretroviral therapy has brought benefits for infective human
      immunodeficiency virus-1 (HIV-1)-patients, reducing the number of AIDS-related morbidity and
      mortality. However, it is responsible for intensifying complications triggered by the chronic
      inflammatory state associated with virus infection, such as cardiovascular diseases. The
      current study evaluated effects of single dose (140mL) of Beetroot Juice (BJ) on macro and
      microvascular endothelial function in HIV-1-patients undergoing antiretroviral terapy, once
      BJ was shown to be effective in improving these physiological parameters in uninfected
      individuals.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 18, 2017</start_date>
  <completion_date type="Actual">November 28, 2018</completion_date>
  <primary_completion_date type="Actual">August 15, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Double- Blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Skeletal Muscle Oxygenation</measure>
    <time_frame>Baseline and approximately after 150 minutes of beetroot juice consumption</time_frame>
    <description>Changes in skeletal muscle oxygenation in response to exercise will be evaluated by using a near-infrared spectroscopy device.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Brachial artery flow-mediated dilatation</measure>
    <time_frame>Baseline and approximately after 150 minutes of beetroot juice consumption</time_frame>
    <description>The brachial artery flow-mediated dilation will be evaluated by using an ultrasound device.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urinary nitrate concentrations</measure>
    <time_frame>Baseline and approximately 30, 90, and 150 minutes after beetroot juice consumption</time_frame>
    <description>Analysis of nitrate in urine will be performed by using high-performance liquid chromatography system.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>HIV/AIDS</condition>
  <arm_group>
    <arm_group_label>Beetroot juice</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Beetroot Juice cotaining on average 9mmol of nitrate per dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo beet juice (Nitrate depleted)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Beetroot juice nitrate depleted</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Beetroot Juice</intervention_name>
    <description>140ml of Beetroot Juice containing on avarege 9 mmol of nitrate</description>
    <arm_group_label>Beetroot juice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>140ml of Beetroot Juice (nitrate free)</description>
    <arm_group_label>Placebo beet juice (Nitrate depleted)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV infection for a period of 1 year or greater

          -  Regular use of high-potency antiretroviral therapy for at least one year

        Exclusion Criteria:

          -  Individuals who are physically active

          -  Individuals who are allergic to some component of beet

          -  Individuals who use nutritional and / or pharmacological ergogenics

          -  Individuals receiving antibiotics or who have osteomioarticular problems
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>DST / AIDS and Viral Hepatitis Program of Macaé</name>
      <address>
        <city>Macaé</city>
        <state>Rio De Janeiro</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>March 13, 2018</study_first_submitted>
  <study_first_submitted_qc>March 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2018</study_first_posted>
  <last_update_submitted>April 25, 2019</last_update_submitted>
  <last_update_submitted_qc>April 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal do Rio de Janeiro</investigator_affiliation>
    <investigator_full_name>Thiago Alvares</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>HIV/AIDS</keyword>
  <keyword>Arterial stiffness</keyword>
  <keyword>Flow mediated-dilatation</keyword>
  <keyword>Muscle oxygenation parameters</keyword>
  <keyword>Microcirculation</keyword>
  <keyword>Dietary Nitrate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

